Trial Profile
Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Jan 2012
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil/pioglitazone (Primary) ; Candesartan cilexetil; Pioglitazone
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Jan 2012 New trial record